// App-Quantinova.ai

273 : Neutropenia With Tocilizumab Treatment Is Not Associated With Increased Infection Risk In Patients With Systemic Juvenile Idiopathic Arthritis

Researchers

Presenter

  • Fabrizio De Benedetti

Principal Investigators

  • Hermine Brunner

  • Eileen M. Baildam

  • Daniel J. Lovell

  • Alberto Martini

  • Nicolino Ruperto

  • Ruben Burgos-Vargas

  • Gerd Horneff

  • Hans-Iko Huppertz

  • Kirsten Minden

  • Barry L. Myones

  • Karen Onel

  • Jianmei Wang

  • Kamal N. Bharucha

Medical Centers

  • PRINTO, Genoa, Italy

  • Pediatria II, Istituto Giannina Gaslini, Genova, Italy

  • PRCSG, Cincinnati, OH

  • Ospedale Pediatrico Bambino Gesu, Rome, Italy.

  • Pediatric Rheumatology, Univ of Chicago, Chicago, IL

  • Childrens University Hospital Charite/German Rheumatism Research Centre Berlin, Berlin, Germany

Locations

  • United States

  • Germany

  • Italy

Companies

  • F. Hoffmann-La Roche

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Rheumatoid arthritis

  • Neutropenia

  • Inflammatory Arthritis

Biomarkers

  • Circulating tumor cells

Drug/Treatment

  • Tocilizumab

Outcome

  • N/A

Study Design

  • randomized

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved